#Breaking #News #USA
The Private Equity Firm That Quietly Profits on Top-Selling Drugs
#Business Day
By @RANDALL SMITH from NYT
The little-known Royalty Pharma has built a portfolio of rights to drug-sale royalties now valued at $15 billion while largely avoiding public controversy.
http://ift.tt/2sAhBBC
The Private Equity Firm That Quietly Profits on Top-Selling Drugs
#Business Day
By @RANDALL SMITH from NYT
The little-known Royalty Pharma has built a portfolio of rights to drug-sale royalties now valued at $15 billion while largely avoiding public controversy.
http://ift.tt/2sAhBBC
Comments
Post a Comment